Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DCLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHROOM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLRX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35F3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMKN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNMT3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBGCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4723 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPGS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF40A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
INIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on